Description: Over the past month, the evolution of the COVID-19 pandemic has raised questions on how this outbreak will impact life insurance industry claims. This report pulls emerging U.S. COVID-19 hospitalization data and deaths obtained from the Centers for Disease Control and Prevention’s (CDC) COVIDView, a Weekly Surveillance Summary of U.S. COVID-19 activity, and compares it to data from past U.S. influenza seasons obtained from the CDC’s Flu Activity and Surveillance webpage.

Description: The goal of the third survey in this series is to collect and disseminate information on best practices around sales and the issuance of new business. The survey was directed at staff directly involved in assessing the impact of recent events on new business processes.

Description: The SOA Research Institute engaged Milliman to perform a study examining life insurer practices on accelerated underwriting and how COVID-19 has impacted them. This effort included a separate outreach to actuaries working for twelve different state insurance departments. At the time of this report, three responses to our regulatory survey had been received. Therefore, the results of the three-question survey are discussed in broad terms, rather than using numerical measurements.

Description: The Individual Life Experience Committee has completed their latest report on intercompany mortality experience by amount of insurance under standard individually underwritten issues. This includes study years 2009-2015.

Description: The Society of Actuaries Product Development Section, the Modeling Section, the Reinsurance Section and the Financial Reporting Section announce the release of a new research report that introduces a novel framework for leveraging the "architecture" of an industry mortality table within a company's predictive analytics-based insured mortality analysis.

Description: This report utilizes a literature review, company survey, company interviews and/or other methods to catalog a listing of common living benefit riders. It was sponsored by the Product Development and Reinsurance Sections along with the Committee on Life Insurance Research. This paper has several goals in relation to each living benefit rider type: to define various living benefit riders, to provide historical sales data and general filing requirements, to explore how underwriting and administration is handled, and to comment briefly on the overall level of claims activity experienced thus far compared to pricing expectations. In addition, it includes a review of the direct and reinsurance pricing implications of the riders to the extent they impact policyholder optionality and base plan financial characteristics. This paper includes perspectives developed through the experience of the authors, and includes executive summaries of a survey conducted by the SOA and Milliman of 34 direct writers, and interviews that Milliman conducted with 8 reinsurers.

Description: Authored by a MIB Solutions team of Tom Rhodes, Stuart Klugman, Marianne Purushotham and Stacy Gill, the report summarizes the results of a study on the application and adoption of credibility theory within the life insurance and annuity industry. In addition to the report, numerical examples related to the application of credibility to company mortality and lapse data are provided in the four Excel files. This excel spreadsheet is a numerical example relating to the application of Credibility for mortality. Please see the SOA website research section for the complete report on Credibility Theory Practices.

Description: Sent to potential participants to gather information on different preferred class structures.

Description: Using recently updated data from the United States Mortality Database (USMDB, usa.mortality.org), this report presents an overview of historical mortality trends in all 50 U.S. states and the District of Columbia for the period 1959-2018.

Description: This report summarizes the results of a 2022 survey examining mortality improvement practices of life and annuity companies in the U.S. and Canada.